Long-Chain Acylcarnitines and Monounsaturated Fatty Acids Discriminate Heart Failure Patients According to Pulmonary Hypertension Status

Defects in fatty acid (FA) utilization have been well described in group 1 pulmonary hypertension (PH) and in heart failure (HF), yet poorly studied in group 2 PH. This study was to assess whether the metabolomic profile of patients with pulmonary hypertension (PH) due HF, classified as group 2 PH,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tremblay-Gravel, Maxime, Fortier, Annik, Baron, Cantin, David, Chloé, Mehanna, Pamela, Ducharme, Anique, Hussin, Julie, Hu, Qinghua, Tardif, Jean-Claude, Des Rosiers, Christine, Dupuis, Jocelyn, Ruiz, Matthieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066759/
https://www.ncbi.nlm.nih.gov/pubmed/33810372
http://dx.doi.org/10.3390/metabo11040196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066759/
https://www.ncbi.nlm.nih.gov/pubmed/33810372
http://dx.doi.org/10.3390/metabo11040196

Ejemplares similares